The 20 Best Methicillin-Resistant Staphylococcus Aureus (MRSA) Doctors in The United States

Vance Fowler is an Infectious Disease provider in Durham, North Carolina. Dr. Fowler has been practicing medicine for over 33 years and is rated as an Elite provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Sepsis, Endocarditis, Methicillin-Resistant Staphylococcus Aureus (MRSA), and Infective Endocarditis.

. Dr. Youssef is rated as a Distinguished provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Sepsis, Endocarditis, Pneumonia, and Cellulitis.

Michael David is an Infectious Disease provider in Philadelphia, Pennsylvania. Dr. David is rated as an Elite provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Sepsis, Osteomyelitis, Osteotomy, and Aneurysm Repair. Dr. David is currently accepting new patients.

. Dr. Ibrahim is rated as a Distinguished provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Infective Endocarditis, Infectious Arthritis, Methicillin-Resistant Staphylococcus Aureus (MRSA), and Hospital-Acquired Pneumonia.

Cesar Arias is an Infectious Disease provider in Houston, Texas. Dr. Arias is rated as an Elite provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Endocarditis, Sepsis, and Pseudomonas Stutzeri Infections.

Dr. Mody is one of very few internists in this country with an expertise in aging populations, epidemiology, an active research laboratory in microbiology and a translational research agenda focused on vulnerable aging population. She has mentored several junior faculty, fellows, post-doctoral students and residents in conducting clinical, epidemiologic as well as laboratory-based research projects and has had uninterrupted NIH funding since 2003. In 2015, she received a 5-year NIH K24 Midcareer Investigator Award to mentor junior faculty in translational aging, infectious diseases and health outcomes research. Her NIH and AHRQ funded work has created a thriving consortium of post-acute and long-term care facilities in SE Michigan interested in developing interventions to enhance infection prevention in a traditionally resource poor setting. In an NIH-R01 study (PI: Mody), her team evaluated a multi-modal targeted infection-prevention (TIP) intervention to prevent resistant organisms and infections in long-term care residents with indwelling devices. This study has garnered national attention and spurred several subsequent pilot projects. Our group (PIs: Saint, Mody) has been awarded an AHRQ contract to implement lessons learnt from this model to 500 federal and non-federal post-acute and long-term care facilities across 50 states in the US. Funded by another concurrent NIH-R01 (PI: Mody), her team is defining the complex relationship between antimicrobial resistance, caregiver and environmental contamination, and functional disability in post-acute care facilities. In order to understand transmission dynamics within post-acute and long-term care facilities, she is collaborating with other national leaders to evaluate spread of organisms from a resident to healthcare worker gown and gloves. She is nationally active at several research methodology and career development activities at the American Geriatrics Society, Society for Healthcare Epidemiology of America and the Infectious Diseases Society of America. Dr. Mody is rated as an Elite provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Urinary Tract Infection (UTI), Asymptomatic Bacteriuria, Severe Acute Respiratory Syndrome (SARS), and Hormone Replacement Therapy (HRT).

Keith Kaye is an Allergy and Immunologist in New Brunswick, New Jersey. Dr. Kaye is rated as an Elite provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Pneumonia, Hospital-Acquired Pneumonia, Sepsis, and Hip Resurfacing.

Mary Hayden is an Infectious Disease provider in Chicago, Illinois. Dr. Hayden is rated as an Elite provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Severe Acute Respiratory Syndrome (SARS), COVID-19, Sepsis, and Gastrostomy.

Daniel Diekema is an Infectious Disease provider in Iowa City, Iowa. Dr. Diekema has been practicing medicine for over 37 years and is rated as an Elite provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Sepsis, Severe Acute Respiratory Syndrome (SARS), and COVID-19.

Eli Perencevich is an Infectious Disease provider in Iowa City, Iowa. Dr. Perencevich is rated as an Elite provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Sepsis, Pneumonia, and Severe Acute Respiratory Syndrome (SARS).

. Dr. Shams is rated as an Advanced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Osteomyelitis, Osteomyelitis in Children, Lymphangitis, and Methicillin-Resistant Staphylococcus Aureus (MRSA).

George Sakoulas is an Infectious Disease provider in San Diego, California. Dr. Sakoulas is rated as an Elite provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Sepsis, Endocarditis, and Osteomyelitis.

Marcus Zervos is an Internal Medicine provider in Detroit, Michigan. Dr. Zervos is rated as an Elite provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Sepsis, Pneumonia, Hospital-Acquired Pneumonia, and Septoplasty.

Curtis Donskey is an Infectious Disease provider in Cleveland, Ohio. Dr. Donskey is rated as an Elite provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Asymptomatic Bacteriuria, Severe Acute Respiratory Syndrome (SARS), and COVID-19.

James Mckinnell is an Infectious Disease provider in Torrance, California. Dr. Mckinnell has been practicing medicine for over 22 years and is rated as an Elite provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), COVID-19, Sepsis, and Multisystem Inflammatory Syndrome in Children (MIS-C).

Robert Weinstein is an Infectious Disease provider in Chicago, Illinois. Dr. Weinstein is rated as an Elite provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Long Haul COVID, Severe Acute Respiratory Syndrome (SARS), and Sepsis.

Matthew Samore is an Internal Medicine provider in Salt Lake City, Utah. Dr. Samore is rated as an Elite provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Pneumonia, COVID-19, Severe Acute Respiratory Syndrome (SARS), and Endoscopy.

Kyle Popovich is an Infectious Disease provider in Chicago, Illinois. Dr. Popovich is rated as an Elite provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). Her top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), HIV/AIDS, Sepsis, and Myelitis.

Martin Evans is an Infectious Disease provider in Lexington, Kentucky. Dr. Evans is rated as an Elite provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Inappropriate Sinus Tachycardia (IST), Viral Gastroenteritis, and Severe Acute Respiratory Syndrome (SARS).

. Dr. Patel is rated as an Advanced provider by MediFind in the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA). His top areas of expertise are Infective Endocarditis, Hospital-Acquired Pneumonia, Lymphangitis, and Pneumonia.